These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24052436)

  • 21. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. XRCC1 Arg399Gln polymorphism is not associated with breast cancer in Chinese.
    Guo S; Mao X; Ming L
    Int J Clin Exp Med; 2015; 8(7):10429-36. PubMed ID: 26379833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of RAD51 G135C and XRCC1 Arg399Gln polymorphisms on ovarian carcinoma risk in Serbian women.
    Malisic EJ; Krivokuca AM; Boljevic IZ; Jankovic RN
    Cancer Biomark; 2015; 15(5):685-91. PubMed ID: 26406958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the association between XRCC1 Arg399Gln polymorphism and glioma susceptibility.
    Zhu W; Yao J; Li Y; Xu B
    Tumour Biol; 2014 Apr; 35(4):3061-6. PubMed ID: 24258108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Wang L; Yin F; Xu X; Hu X; Zhao D
    PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z; Hu X; Long J; Su L; Wei B
    Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-ray repair cross-complementing gene 1 Arg399Gln polymorphism and glioma risk among Asians: A meta-analysis based on 2 326 cases and 3 610 controls.
    Zhang L; Qiu Z; Luo J; Shu W
    Neural Regen Res; 2012 Oct; 7(29):2313-9. PubMed ID: 25538755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
    Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP
    DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and prostate cancer risk.
    He F; Li G; Man L; Liu N
    Tumour Biol; 2014 May; 35(5):4041-5. PubMed ID: 24492938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis.
    Zhou C; Zhou Y; Li J; Zhang Y; Jiang L; Zeng X; Feng X; Wang Z
    Tohoku J Exp Med; 2009 Sep; 219(1):43-51. PubMed ID: 19713684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
    PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B
    Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
    Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
    Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
    Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of XRCC1 Arg399Gln Polymorphism with Colorectal Cancer Risk: A HuGE Meta Analysis of 35 Studies.
    Forat-Yazdi M; Gholi-Nataj M; Neamatzadeh H; Nourbakhsh P; Shaker-Ardakani H
    Asian Pac J Cancer Prev; 2015; 16(8):3285-91. PubMed ID: 25921133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
    Geng J; Zhang YW; Huang GC; Chen LB
    World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.